论文部分内容阅读
目的探讨低分子肝素钠联合纳络酮治疗急性脑梗死的临床疗效。方法 65例急性脑梗死患者,随机分为观察组(30例)和对照组(35例)。对照组给予右旋糖酐、胞二磷胆碱药物等的基础治疗,观察组在此基础上给予低分子肝素及纳洛酮治疗,比较两组的临床疗效。结果观察组总有效率为83.4%,对照组总有效率为51.5%,两组比较差异有统计学意义(P<0.05)。结论低分子肝素钠联合纳络酮可显著提高急性脑梗死的临床疗效,值得在临床中推广应用。
Objective To investigate the clinical efficacy of low molecular weight heparin combined with naloxone in the treatment of acute cerebral infarction. Methods Sixty-five patients with acute cerebral infarction were randomly divided into observation group (30 cases) and control group (35 cases). Control group given dextran, citicoline drugs and other basic treatment, the observation group on the basis of low molecular weight heparin and naloxone treatment, the clinical efficacy of the two groups were compared. Results The total effective rate was 83.4% in the observation group and 51.5% in the control group, with significant difference between the two groups (P <0.05). Conclusion Low molecular weight heparin combined with naloxone can significantly improve the clinical efficacy of acute cerebral infarction, it is worth promoting in clinical application.